More health news you should know about. An experimental class of cholesterol-lowering drugs is showing a lot of promise for up to 70 million Americans suffering from heart-related diseases and could generate $3 billion in annual sales for the companies racing to get those new medications on the market.
About NBR“Nightly Business Report produced by CNBC” (NBR) is an award-winning and highly-respected nightly business news program that airs on public television. Television’s longest-running evening business news broadcast, “NBR” features in-depth coverage and analysis of the biggest financial news stories of the day and access to some of the world’s top business leaders and policy makers.
- Dow futures rise more than 100 points after Wall Street's losing week
- Biden won't lift Europe, Brazil travel restrictions despite Trump order, spokeswoman says
- Biden Covid advisor challenges Cuomo's letter to buy vaccine directly from Pfizer
- New York Gov. Cuomo asks to buy Covid vaccine directly from Pfizer amid dose shortages
- Foreigners poured money into China as the world struggled with the coronavirus pandemic
NBR on TwitterMy Tweets
Subscribe to RSS